Basic Information
ID: ALA4825215
Type: Functional
Description: Antiviral activity against SARS-CoV-2 infected in 16HBE14o- cells assessed as inhibition of viral replication after 1 day by Nano-Glo luciferase assay
Format: BAO_0000218
Organism: Severe acute respiratory syndrome coronavirus 2
Cell type: 16HBE14o-
Target: SARS-CoV-2(ALA4303835)
Document: ALA4823308
Antiviral activity against SARS-CoV-2 infected in 16HBE14o- cells assessed as inhibition of viral replication after 1 day by Nano-Glo luciferase assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4825215
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 602.59 | 2.31 | 2.31 |
| 441.92 | 5.88 | 5.88 |
| 495.89 | 6.42 | 6.42 |
| 453.93 | 5.88 | 5.88 |
| 565.39 | 4.98 | 4.98 |
| 587.97 | 4.66 | 4.66 |
| 519.97 | 3.94 | 3.94 |
| 551.36 | 4.97 | 4.97 |
| 494.94 | 5.97 | 5.97 |
| 476.92 | 3.40 | 3.40 |
| 518.88 | 3.94 | 3.94 |
| 573.94 | 4.65 | 4.65 |
| 557.87 | 4.18 | 4.18 |